The role of respiratory rehabilitation in chronic obstructive pulmonary disease (COPD), outpatients under long term oxygenotherapy (LTOT) Source: Eur Respir J 2004; 24: Suppl. 48, 634s Year: 2004
Poor compliance with guidelines for prescription of long-term oxygen therapy (LTOT) in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - Palliative care, oxygen and community care for chronic lung disease Year: 2010
Quality of life in patients with chronic obstructive pulmonary disease (COPD) and long-term oxygen therapy (LTOT) Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001
Treatment patterns of patients with chronic obstructive pulmonary disease (COPD) in Ontario, Canada Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021
Liquid long-term oxygen therapy (LTOT) improves health status in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 709s Year: 2005
Healthcare costs and resource use in patients with chronic obstructive pulmonary disease (COPD) in Ontario, Canada Source: Virtual Congress 2021 – Primary care organisation and epidemiology Year: 2021
Exacerbations in chronic obstructive pulmonary disease (COPD) in Ontario, Canada Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2 Year: 2021
Long term pulmonary rehabilitation programs for crhonic obstructive pulmonary disease (COPD). Two years follow-up Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011
Long term effects of PAP therapy on patients with obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD) (overlap syndrome) Source: Sleep and Breathing Conference 2021 Year: 2021
Quality of life and disease burden of chronic obstructive pulmonary disease (COPD) patients in Northern Greece – The INCARE* study Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015
Home mechanical ventilation (HMV) and long term oxygen therapy (LTOT) in chronic respiratory failure (CRF) due to very severe COPD Source: Eur Respir J 2006; 28: Suppl. 50, 186s Year: 2006
Indacaterol/glycopyrronium (IND/GLY) is cost-effective compared with salmeterol/fluticasone (SFC) in Swedish chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD Year: 2017
The impact of The Danish Oxygen Register on adherence to guidelines for long term oxygen therapy in COPD patients Source: Annual Congress 2005 - Chronic care in respiratory failure Year: 2005
Awareness of chronic obstructive pulmonary disease (COPD) in Portugal Source: Eur Respir J 2007; 30: Suppl. 51, 126s Year: 2007
Audit of inhaled corticosteroid prescription in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - COPD: management Year: 2010
Home non-invasive ventilation (NIV) adherence for chronic respiratory failure treatment of obesity hypoventilation syndrome (OHS) vs. chronic obstructive lung disease (COPD) Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019
Chronic obstructive lung disease (COPD) and long term oxygen treatment Source: International Congress 2017 – Patient experience of smoking cessation: new approaches Year: 2017
Use of spirometry screening for patients with chronic obstructive pulmonary disease (COPD) requiring oxygen therapy Source: Eur Respir J 2006; 28: Suppl. 50, 838s Year: 2006
Adherence to national (UK) respiratory guidelines in general practice Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care Year: 2007
Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – COPD diagnosis and management Year: 2016